Orpyx Medical Technologies Inc.

Orpyx Medical Technologies Inc. Leading digital therapeutics company extending healthspan for people living with diabetes.

Orpyx is a leading digital therapeutics company that is committed to extending healthspan for people living with diabetes through personalized remote care. Our flagship product, the Orpyx SI® Sensory Insoles, is transforming diabetes care by helping prevent diabetic foot ulcers, a major complication of diabetes that can lead to amputation. Our dedicated remote patient monitoring team, comprised of

credentialed providers and nurses, utilizes advanced data science methodologies to provide personalized support and triaged clinical escalation. With our whole-person approach, Orpyx empowers people to take control of their health, prevent debilitating complications and extend their healthspan.

What an incredible week at the Orpyx Analytics and Scientific Insights Summit!We were honored to bring together healthca...
03/30/2026

What an incredible week at the Orpyx Analytics and Scientific Insights Summit!

We were honored to bring together healthcare providers, podiatrists, researchers, and innovators who are deeply committed to advancing diabetic foot care and limb preservation. The level of engagement, collaboration, and shared purpose throughout the program was truly inspiring.

From meaningful discussions on prevention and early intervention to emerging evidence in continuous foot monitoring and real-world implementation, this event’s conversations reflected both the urgency of the challenge, and the momentum building toward better outcomes.

Diabetes-related foot disease remains one of the most complex and costly complications in healthcare today. Events like OASIS remind us that progress is possible when we come together with focus, expertise, and a shared commitment to change.

Thank you to everyone who joined us in Calgary and Banff, contributed your insights, and helped move this important work forward. The conversations don’t end here, and neither does the work. Together, we are advancing a future focused on prevention, preservation of mobility, and better patient outcomes.

Breanne is presenting at   today to share insights on continuous foot monitoring. Catch her session at 4:40 p.m. in Mona...
03/17/2026

Breanne is presenting at today to share insights on continuous foot monitoring. Catch her session at 4:40 p.m. in Monarch 1.

02/11/2026

On the International Day of Women and Girls in Science, Dr. Emily Matijevich shares how Continuous Foot Monitoring is helping reshape diabetic foot care.

The future of foot health is supportive.

Exciting progress in DFU prevention research, recently featured in Vascular News. The NIH-funded WIREDUP trial will eval...
01/19/2026

Exciting progress in DFU prevention research, recently featured in Vascular News. The NIH-funded WIREDUP trial will evaluate a patient-facing app paired with continuous foot monitoring through the Orpyx Sensory Insole program.

Orpyx’s technology powers the data ecosystem in this study led by Caitlin Hicks at Johns Hopkins University, helping detect high plantar pressure and temperature changes before serious complications occur.

Read the full article here:

The WIREDUP trial is due to commence this month to assess the efficacy of continuous digital monitoring in reducing diabetic foot ulcer recurrence.

Empowering Veterans with the right education and support helps them take control of their foot health. Understanding ear...
01/14/2026

Empowering Veterans with the right education and support helps them take control of their foot health. Understanding early warning signs, like pressure and temperature changes, can prevent small complications from becoming serious ones.

In a recent interview, Yvette shared how she improves Veteran engagement through education and relationship-building. Her approachable style and commitment to clear communication help Veterans and their families better understand the benefits of the Orpyx Sensory Insole Program and how it supports proactive foot health management.

From all of us at Orpyx, we wish you and your loved ones a joyful holiday season and a New Year filled with good health,...
12/23/2025

From all of us at Orpyx, we wish you and your loved ones a joyful holiday season and a New Year filled with good health, purpose, and momentum.

We’re proud to partner with Dr. James Chadburn, a leader in diabetic foot care at the University of Texas Rio Grande Val...
12/17/2025

We’re proud to partner with Dr. James Chadburn, a leader in diabetic foot care at the University of Texas Rio Grande Valley School of Podiatric Medicine and the VA Health Care Center at Harlingen. His firsthand experience shows how collaboration and innovation are shaping the future of diabetic foot care.

12/11/2025

Our remote Nursing Team builds deep connections with people enrolled in the Orpyx program by sharing practical footcare tips and personalized support to help them stay active and independent.

Meet Erin, our Director of Nursing. She ensures our nurses have the tools they need to support and connect with users, and she partners with providers during clinical rounds to strengthen collaboration across the care team.

Thank you, Erin, and the entire Orpyx Nursing Team, for the incredible work you do every day!

Grateful for the dedicated professionals who help drive innovation in diabetic foot care. Happy Thanksgiving from all of...
11/27/2025

Grateful for the dedicated professionals who help drive innovation in diabetic foot care. Happy Thanksgiving from all of us at Orpyx.

On World Diabetes Day we’re celebrating the little things. Small steps in the right direction that make a big impact for...
11/14/2025

On World Diabetes Day we’re celebrating the little things. Small steps in the right direction that make a big impact for people living with diabetes. ​

11/13/2025

We’re proud to announce that Orpyx’s digital health platform has been selected for use in the NIH-funded WIREDUP trial on diabetic foot ulcer prevention, led by Caitlin Hicks at The Johns Hopkins University School of Medicine, with collaborators David Armstrong at the University of Southern California, and University of Utah School of Medicine.

This $5M R01-funded randomized controlled trial will enroll 400 participants to evaluate whether integrating continuous digital foot monitoring into routine care can help prevent diabetic foot ulcers, one of the most serious and costly complications of diabetes.

“Supporting independent, peer-reviewed research is central to advancing care for people with diabetes,” said Dr. Breanne Everett, CEO & Founder of Orpyx. “We are honored our platform will contribute to high-quality evidence on the role of digital tools in DFU prevention.”

Read the full announcement:

Orpyx’s sensory insoles and digital health platform will be used in a $5M NIH-funded trial led by Johns Hopkins to prevent diabetic foot ulcers. The study will explore whether continuous digital foot monitoring can reduce one of the most serious complications of diabetes.

Address

Suite 205, 1240 – 20th Avenue S. E
Calgary, AB
T2G1M8

Opening Hours

Monday 8am - 4pm
Tuesday 8am - 4pm
Wednesday 8am - 4pm
Thursday 8am - 4pm
Friday 8am - 4pm

Alerts

Be the first to know and let us send you an email when Orpyx Medical Technologies Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Orpyx Medical Technologies Inc.:

Share